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Abstract
Photoacoustic tomography (PAT) of genetically encoded probes allows imaging of targeted 
biological processes with high spatial resolution at depths. Here, we combined multi-scale 
photoacoustic imaging with, for the first time, a reversibly switchable non-fluorescent bacterial 
phytochrome BphP1. With a heme-derived biliverdin chromophore, BphP1 has the most red-
shifted absorption among reported genetically encoded probes, and is reversibly photoconvertible 
between its red and near-infrared light absorption states. We combined single-wavelength PAT 
with efficient BphP1 photoswitching, enabling differential imaging that substantially removed 
background signals, enhanced detection sensitivity, increased penetration depth, and improved 
spatial resolution. In doing so, we monitored tumor growth and metastasis with a ~100 µm 
resolution at depths approaching 10 mm using photoacoustic computed tomography, and imaged 
individual cancer cells with a sub-optical-diffraction resolution of ~140 nm using photoacoustic 
microscopy. This technology is promising for biomedical studies at different length scales.
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INTRODUCTION
Optical imaging has provided valuable information for biomedical studies1, 2. However, 
strong light scattering in tissue leads to a substantial tradeoff between the spatial resolution 
and penetration depth3. Photoacoustic (PA) tomography (PAT), on the other hand, breaks the 
depth and resolution limitations of pure optical imaging by acoustically detecting optical 
absorption contrast (Online Methods)4. The weak ultrasonic scattering in soft tissue provides 
PAT with highly scalable spatial resolution and penetration5–11. PAT is inherently suited for 
molecular imaging by using genetically encoded optical probes that are either fluorescent or 
not
12
–
15
. Genetically encoded optical probes with the following characteristics are highly 
desired in PAT: (i) Spectral properties that allow light penetration to deep tissues and robust 
unmixing from other endogenous biomolecules, (ii) light-sensing chromophores that are 
naturally present in tissues, (iii) orthogonality to mammalian cell metabolism. Fortunately, 
bacterial phytochromes (BphPs), among the very few light-sensing protein classes, can meet 
these criteria.
BphPs are photoreceptors sensitive to 600–800 nm light16, a wavelength range that falls into 
the deep-penetration optical window in tissue17. BphPs consist of a photosensory core 
module and an output effector domain (Supplementary Fig. 1a). The spectral properties of 
BphPs are defined by a covalently attached chromophore, biliverdin IXα (BV) 
(Supplementary Fig. 1b)18. Inside a chromophore binding pocket, photoisomerization of BV 
leads to two conformational states, Pfr and Pr, resulting in absorption spectrum shift 
(Supplementary Fig. 1c)19. For unbound BV molecules in cells, photoisomerization occurs 
does not induce changes in the absorption spectrum (Supplementary Fig. 1d).
Here, we report a novel imaging approach, which, for the first time, combines PAT with a 
RpBphP1 phytochrome from the bacterium Rhodopseudomonas palustris (termed below as 
BphP1). Two embodiments of PAT—photoacoustic computed tomography (PACT) and 
photoacoustic microscopy (PAM)4—were investigated at different length scales. 
Capitalizing on BphP1’s reversible switching, we showed that this imaging approach 
dramatically enhanced the detection sensitivity of PACT at large depths. We demonstrated 
the high detection sensitivity in vivo by imaging the growth of BphP1-expressing tumors and 
monitoring the tumor metastases over prolonged periods of time. We extended this imaging 
approach to super-resolution PAM, achieving substantially finer spatial resolutions and 
higher image contrast.
RESULTS
Comparison of BphP1 with available genetically encoded probes
BphP1 has a natural photochromic behavior: it adopts a Pfr state as the ground state, and 
undergoes the Pfr→Pr photoconversion upon 730–790 nm light illumination and the Pr→Pfr 
photoconversion upon 630–690 nm light illumination. From here on, we choose the Pfr state 
of BphP1 as the ON state, and the Pr state as the OFF state, and used 780 nm light for 
Pfr→Pr photoconversion and 630 nm light for Pr→Pfr photoconversion. The molar 
extinction coefficients of the ON state BphP1 at 780 nm and of the OFF-state at 630 nm are 
respectively ~70-fold and ~40-fold higher than that of oxy-hemoglobin (HbO2) (Fig. 1a, 
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Table 1). We compared BphP1 with the so far reported most red-shifted NIR fluorescent 
protein (FP), iRFP720, engineered from another BphP20. While the peak absorption of 
iRFP720 at 705 nm is comparable to that of the ON state BphP1 at 780 nm, iRFP720 is not 
photoswitchable (Supplementary Fig. 2a, Table 1). We also compared BphP1 with the so far 
reported most red-shifted photoswitchable FP, rsTagRFP, which can be photoswitched by 
altering light illumination between 440 nm and 570 nm21, 22. BphP1 was clearly 
advantageous over rsTagRFP for deep-tissue imaging because of its 2-fold higher extinction 
coefficient and ~200 nm red-shifted absorption (Supplementary Fig. 2a, Table 1).
We upgraded our whole-body PACT system to utilize BphP1 (Fig. 1b, Online Methods, 
Supplementary Video 1)23. We selected three wavelengths at 567 nm, 715 nm and 780 nm, 
based on the absorption spectra of the proteins and the power spectra of the lasers. Plastic 
tubes with purified proteins (~30 µM) were first immersed in water for PA imaging 
(Supplementary Fig. 2b). The laser fluence (8 mJ/cm2) at all three wavelengths was within 
the ANSI safety limit for laser exposure (20 mJ/cm2 at 567 nm; 40 mJ/cm2 at 715 nm and 
780 nm). The results clearly suggest the superior PA signal generation of ON state BphP1 at 
780 nm (Fig. 1c). Purified proteins were then embedded at different depths in scattering 
media (1% intralipid and 10% gelatin in distilled water; reduced scattering coefficient of ~10 
cm−1) (Fig. 1d)24. The PA signal amplitude at 10 mm depth dropped by ~32-fold for BphP1 
at 780 nm, ~101-fold for iRFP720 at 715 nm, and ~320-fold for rsTagRFP at 567 nm (Fig. 
1e, Table 1). The noise equivalent detection concentration (NEC) was 2.0 ± 0.9 µM for 
BphP1 at 780 nm at 10 mm depth (Fig. 1f).
Characterization of reversible photoswitching of BphP1
Reversible photoswitching is an important feature of BphP1 for PAT, which enables 
differential imaging with a sensitivity, in principle, limited only by the noise level14, 25, 26. 
The photoswitching of BphP1 consists of a cis-trans photoisomerization of the D-ring of the 
biliverdin chromophore around its C15=C16 double bond (Supplementary Fig. 1c)27. 
Because the D-ring can rotate only in one direction, the intermediate conformations during 
the cis→trans and trans→cis photoswitching are different, resulting in different Pr→Pfr and 
Pfr→Pr photoswitching rates (Fig. 2a). Once BphP1 is photoswitched to the OFF state, it 
naturally relaxes back to the ON state with a half-life time of ~210 seconds. Multiple 
switching cycles did not cause photobleaching of BphP1. Because BphP1 photoswitching is 
a one-photon process, the photoswitching rate is approximately proportional to the switching 
light intensity (Fig. 2b), similar to photoswitchable FPs21, 25, 28.
We evaluated photoswitching of BphP1 in scattering media at different depths using PACT 
(termed RS-PACT). Here, we define switching ratio as the ratio between the PA signal 
amplitudes measured in the ON and OFF states of BphP1. Each switching cycle began with 
16 seconds of 780 nm light illumination for both PA imaging and switching off BphP1, 
followed by 16 seconds of 630 nm light illumination only for switching on the protein (Fig. 
2c). During the first 3.2 seconds of a switching cycle, a 630 nm laser pulse was fired 72 µs 
after each 780 nm laser pulse to maintain the protein population in the ON state. We used the 
PA images acquired during the first and the last 3.2 seconds of the 780 nm light illumination 
as the ON state and OFF state images, respectively. Pixelwise subtraction of the OFF image 
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from the ON image generated a differential image. The switching wavelengths for other 
proteins were adjusted accordingly. Unless otherwise stated, a global threshold was applied 
to differential images, with a threshold level set at three times the noise level—estimated as 
the standard deviation of the background signal outside the imaged region.
HbO2 and iRFP720 could not be photoswitched (Fig. 2d, Supplementary Fig. 3). rsTagRFP 
had a switching ratio of 8.5 ± 0.3 in clear media, but it essentially could not be 
photoswitched at depths beyond 3 mm, due to the strong light attenuation at 440 nm and 567 
nm (Table 1). BphP1, however, maintained its photoswitching capability at 630 nm and 780 
nm with increased depth, only reducing the switching ratio from 4.3 ± 0.2 in clear media to 
2.8 ± 0.2 at 10 mm depth (Fig. 2d, Table 1). We imaged the three proteins at 10 mm depth 
with oxygenated whole bovine blood as a reference (Fig. 1d). We quantified the contrast 
(difference between proteins and blood) to noise ratio (CNR) of the ON state and differential 
PA images (Fig. 2e, Table 1). The differential PA image of BphP1 had ~21-fold 
enhancement in CNR than its ON state image (Fig. 2f). The red and NIR switching of 
BphP1 is clearly advantageous for deep PA imaging.
RS-PACT of BphP1 in mammalian cells and in vivo
We used U87 human glioblastoma cells to stably express BphP1 (Online Methods). 
Because BphP1 is non-fluorescent, we used a plasmid containing an internal ribosome entry 
site between BphP1 and EGFP. Both genes were translated from a single bicistronic mRNA 
(Supplementary Fig. 4a). We used the co-expressed EGFP to select stable BphP1-expressing 
cells, study the cytotoxicity of BphP1, and validate the PA imaging.
We imaged BphP1-expressing U87 cells embedded in scattering media (1% intralipid, 10% 
gelatin, and 2% oxygenated bovine blood in distilled water; absorption coefficient of 0.1 
cm−1; reduced scattering coefficient of ~10 cm−1) at 10 mm depth using RS-PACT. The PA 
images acquired before and after the photoswitching both had strong background signals 
from blood, resulting in poor image contrast of the U87 cells (Supplementary Fig. 4b). By 
contrast, the differential image, averaged over 20 switching cycles, largely removed the non-
switchable background signals and achieved a 50-fold enhancement in CNR (Supplementary 
Fig. 4c). Multiple switching cycles did not cause photobleaching of the cells (Supplementary 
Fig. 4d). We observed a noise-equivalent detection sensitivity of ~20 cells by using 
differential PA imaging (Fig. 3a).
We compared the new single-wavelength differential method with the traditional two-
wavelength spectral unmixing method (Supplementary Fig. 5). The two-wavelength method, 
based on least-squares fitting, had low accuracy in identifying the cells, largely due to the 
unknown optical fluence inside the scattering phantom. By contrast, the single-wavelength 
differential method can extract the BphP1 signals with greater accuracy, achieving a 34-fold 
enhancement in CNR.
BphP1 has low cytotoxicity, similar to FPs engineered from various natural BphPs20, 25. 
First, we compared cell viability of the BphP1-expressing U87 cells with that of the wild-
type U87 cells by annexin V staining. We observed no difference between the two types of 
cells (Supplementary Fig. 6a). Second, we monitored the BphP1-expressing U87 preclonal 
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cell culture for many generations. We did not observe decrease in the expression levels of 
BphP1 (measured by photoacoustic microscopy) and EGFP (measured by fluorescence 
cytometry) during several weeks of continuous cell culturing (Supplementary Figs. 6b–e).
By using RS-PACT, we imaged a mouse one week after injection of 106 BphP1-expressing 
U87 cells into the left kidney. Major organs, including the skin, kidneys, spleen, bladder, and 
spinal cord, could be delineated with strong signals from blood (Fig. 3b). The U87 tumor in 
the left kidney, overwhelmed by the blood signals, could not be detected. By contrast, after 
20-cycle photoswitching, the differential PA image clearly showed the tumor at a depth up to 
~8 mm, with an average CNR of ~20 (Fig. 3c). The photoswitchable tumor had different 
signals in the ON and OFF state images, while the non-switchable background signals from 
blood were virtually identical (Fig. 3d). After PA imaging, the tumor was histologically 
confirmed (Fig. 3e). RS-PACT was capable of three-dimensional (3D) imaging of a BphP1-
expressing tumor (Supplementary Video 2). The superior sensitivity of BphP1-based RS-
PACT was further demonstrated by comparing the images of a BphP1-expressing U87 tumor 
and a wild-type U87 tumor (Supplementary Fig. 7), and by imaging an otherwise 
undetectable U87 tumor in a mouse brain, at ~3 mm depth beneath the scalp surface (Fig. 3f, 
Supplementary Fig. 8).
Longitudinal RS-PACT of tumor metastases
We longitudinally imaged the growth of a BphP1-expressing U87 tumor in a mouse liver and 
monitored tumor metastases in the liver lobes for a month (n = 6) (Fig. 4a). The differential 
PA images detected the growth of a primary tumor in the right liver lobe, and later the 
secondary tumors resulted from metastatic spread to other liver lobes (Fig. 4a). The smallest 
secondary tumor had an average diameter of ~300 µm. Assuming that the mean diameter of 
U87 cells is ~10 µm, each resolution voxel of the secondary tumor corresponds to ~3000 
U87 cells. The CNR of the above-mentioned tumor is ~15 in the differential image, 
suggesting it is possible to detect as few as ~200 cells at this depth. Over one month, we 
observed an exponential growth of the primary tumor, and a delayed exponential growth of 
the secondary tumor (Fig. 4b). There was no difference between the growth rates of the 
primary tumor (from day 0) and secondary tumors (from day 7). The cross-sectional area 
doubling times of the primary tumor and secondary tumors are respectively 8.0 ± 1.2 days 
and 7.2 ± 2.7 days, suggesting cell doubling times of 5.3 ± 0.8 days and 4.8 ± 1.8 days. 
After the PA imaging, we histologically confirmed the relative locations of the tumors (Fig. 
4c).
Sub-diffraction photoacoustic microscopy of BphP1
By tightly focusing the excitation light, PAT has provided optically-determined spatial 
resolution on the scale of micrometers, a technology referred to as optical-resolution 
photoacoustic microscopy (PAM)4. Here, we demonstrate that BphP1 can improve the image 
contrast of optical-resolution PAM in vivo, and more importantly, break the optical-
diffraction limit for super-resolution PA imaging.
We developed a double-illumination PAM that illuminates the object from above and below 
(Fig. 5a, Online Methods). The top illumination utilizes a 0.1 numerical aperture (NA) 
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objective, and the bottom illumination uses a 1.4 NA oil-immersion objective. Because of its 
relatively large depth of focus (~83 µm), the top illumination is suited for in vivo imaging 
with capillary-level resolution (~3 µm). As a demonstration, we imaged a nude mouse ear 
bearing BphP1-expressing U87 tumors, where the differential image had a ~67-fold greater 
CNR than the ON state image (Supplementary Fig. 9).
Moreover, we developed sub-diffraction PA imaging based on the reversible photoswitching 
of BphP1 (termed RS-PAM) (Fig. 5b, Online Methods, and Supplementary Notes 1–3). 
Briefly, when a train of Gaussian-shaped laser pulses at 780 nm repeatedly strike a group of 
ON-state BphP1 molecules, the PA signals generated by the consecutive laser pulses 
decrease, as more and more BphP1 molecules are inhomogeneously switched off at a rate 
proportional to the local excitation intensity (Supplementary Note 1). The PA signal from 
the center of the excitation spot decays faster than that from the periphery. The detected PA 
signal decay is integrated over all the molecules in the excitation spot. When a polynomial 
function is used to fit the signal decay as a function of time, the high-order coefficient of the 
fitted polynomial imposes non-linear weighting on the signal contributions from the 
excitation spot, accentuating the contribution from the center (Supplementary Note 2). A 
higher-order coefficient has a narrower spatial distribution. RS-PAM extracts the highest-
order coefficient of the polynomial fitting at each pixel as its image contrast, achieving sub-
diffraction spatial resolution29. Note that the highest-order coefficient that can be effectively 
extracted is determined by the signal-to-noise ratio of the original PA signal decay. 
Importantly, by efficiently blocking the out-of-focus signals, RS-PAM provides optical-
sectioning capability for laterally large targets (Supplementary Note 3), which is not 
available in conventional PAM30.
Using the bottom illumination of the PAM system, we demonstrated sub-diffraction lateral 
resolution by imaging a monolayer of BphP1-expressing bacteria densely fixed on a cover 
glass. At each pixel, one hundred laser pulses at 780 nm were used to record the switching-
off dynamics of BphP1. The OFF-state BphP1 molecules were then switched back on with 1 
second of continuous-wave illumination at 630 nm. Compared to the conventional PAM 
image, the RS-PAM image showed superior lateral resolution, enabling better separation of 
neighboring bacteria (Fig. 5c–e). RS-PAM has achieved a lateral resolution of ~141 nm, ~2-
fold finer than that of conventional PAM (Supplementary Fig. 10a).
We demonstrated the axial resolution of RS-PAM on a multilayer of fixed BphP1-expressing 
U87 cells (total thickness: ~35 µm). For laterally large targets, conventional PAM exhibits 
poor axial resolution (~30 µm) as a result of the time-resolved acoustic detection 
(Supplementary Fig. 10b), and therefore was not able to resolve different layers of U87 cells 
(Supplementary Fig. 11). In comparison, RS-PAM was able to block the PA signals 
generated by the out-of-focus cells and consequently achieved thin optical sectioning of ~0.4 
µm, ~75-fold finer than that of conventional PAM (Supplementary Fig. 10b). By a depth 
scanning, RS-PAM clearly resolved U87 cells at different layers (Fig. 5f–g, Supplementary 
Fig. 11, Supplementary Video 3).
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DISCUSSION
We have developed photoacoustic tomography that, for the first time, combines deep-tissue 
PA imaging with a non-fluorescent photochromic NIR bacterial phytochrome, BphP1. With 
this new imaging technology, we have achieved a PA detection sensitivity of tens to 
hundreds of live mammalian cells at a centimeter depth. Moreover, PA imaging of BphP1 
has enhanced the image contrast of optical-resolution PAM in vivo and achieved sub-
diffraction imaging of individual cells.
The above achievements come from BphP1’s unique photochemical features. First, BphP1 
has two red- and NIR-absorbing photoconvertible states, enabling deep-tissue PA imaging 
and photoswitching20. Second, BphP1 is non-cytotoxic and it does not affect cell 
metabolism. Third, BphP1 efficiently and specifically binds endogenous chromophore BV, 
and does not require an exogenous supply. Mammalian cells in different organs generally 
have sufficient BV for BphP1 binding. Fourth, BphP1 exhibits low photoswitching fatigue 
during photoconversion, allowing longitudinal imaging.
Meanwhile, PAT is inherently suited to take maximum advantage of BphP1’s photochemical 
features. First, PAT can provide high-resolution imaging of BphP1 at depths beyond that 
achieved by pure optical techniques26. Second, in comparison to the traditional multi-
wavelength methods31, single-wavelength imaging at 780 nm much reduces the influence of 
unknown local light fluence (J/cm2) on extracting the protein signals. The wavelength-
dependent local light fluence is affected by not only the optical attenuation of the 
intervening tissue but also the local optical absorption31, 32. Third, due to the relatively low 
light attenuation in the red and NIR regions, the switching efficiency of BphP1 can be 
maintained in deep tissue. Lastly, the differential imaging process is simple and reliable. The 
background signals are removed without sacrificing either the spatial resolution or 
sensitivity12, 31.
We have carefully mitigated potential artifacts in our differential images. First, BphP1-
expressing cells had relatively weak absorption. The photoswitching of the cells had 
negligible influence on the total internal optical fluence distribution. Second, for in vivo 
imaging, animal motion was largely reduced by the specially designed animal mounting 
methods (Online Methods). Image averaging over multiple switching cycles further reduced 
motion artifacts. Third, the laser pulse energy fluctuation was less than 3%, and its effect 
was further minimized by multiplexed data acquisition and multi-cycle averaging. Finally, 
signal thresholding removed remaining artifacts.
Further development of the technology may include improvement of the NIR photochromic 
probes, either by engineering the BphP1 properties16 or by seeking better BphPs in nature18. 
Relatively inexpensive continuous-wave laser diodes can be used for photoswitching33. The 
current PACT has a relatively low imaging speed (32 seconds per switching cycle and 11 
minutes with 20 averaging cycles). The imaging speed can be improved by using a 50 Hz 
laser and a 512-channel data acquisition system, which can avoid the data multiplexing and 
thus reduce the imaging time.
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Overall, BphP1-based PAT opens new possibilities for biomedical applications. For example, 
transgenic mouse models that express BphP1 in neurons can be used for longitudinal PA 
monitoring of neural network development34. BphP1-expressing cardiomyocytes should 
allow direct PA imaging of heart activities, which is otherwise challenging due to the large 
amount of blood inside the heart. The high detection sensitivity of BphP1 will be useful for 
capturing non-pigmented cancer cells circulating in the blood stream in deep tissue35, as 
well as for cell tracking in immunotherapy36.
ONLINE METHODS
Photoacoustic tomography (PAT)
In PAT, as photons propagate in tissue, some are absorbed by biomolecules, and their energy 
is partially or completely converted into heat. The heat-induced pressure propagates in tissue 
and is detected outside the tissue by an ultrasonic transducer or transducer array to form an 
image that maps the original optical energy deposition in the tissue. Based on the image 
formation methods, PAT has two major implementations. The first, direct image formation, 
is based on mechanical scanning of a focused single-element ultrasonic transducer, and is 
commonly used in photoacoustic microscopy (PAM). The second, reconstruction image 
formation, is based on parallel detection by an unfocused multi-element ultrasonic 
transducer array or a mechanical/electronic scanning equivalent, and is used in 
photoacoustic computed tomography (PACT).
Plasmid construction and protein expression
The RpBphP1 gene was kindly provided by E. Giraud. For mammalian expression, the 
BphP1 gene was PCR amplified as NheI-BglII fragments and cloned into multi cloning sites 
of the pIRES2-EGFP vector (Takara-Clontech), allowing co-expression of BphP1 and EGFP 
proteins separately but from the same bicistronic mRNA. For bacterial expression of BphP1, 
the pBAD/His-B vector (Life Technologies-Invitrogen) was used.
rsTagRFP and iRFP720 were purified from E. coli bacteria as described before20, 21. BphP1 
with a polyhistidine tag at the N-terminus was expressed in LMG194 bacterial cells (Life 
Technologies-Invitrogen) containing a pWA23h plasmid encoding heme oxygenase for BV 
synthesis in E. coli20, 25. The bacterial cells were grown in RM medium supplemented with 
ampicillin, kanamycin, and 0.02% rhamnose for 6–8 h, followed by induction of protein 
expression by adding 0.002% arabinose. The proteins were purified using a Ni-NTA agarose 
(Qiagen).
Absorption spectra of BphP1, dissolved in phosphate buffered saline, were measured using a 
standard spectrophotometer (Hitachi U-2000) with a 100 µL quartz microcuvette (Starna 
Cells). The spectrum of the ON state BphP1 was measured without a photoswitching light 
source, because the ON state is the ground state (or natural state). To measure the OFF state 
spectrum, photoswitching was performed with a 780/25 nm LED placed above the 
microcuvette. The photoswitching beam direction was orthogonal to the optical beam path 
of the spectrophotometer. The OFF state spectrum was measured after the photoswitching 
was completed and the LED was turned off, so there was no interference with the 
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measurements. Because of the extremely low light intensity (<1 µW/cm2), changes in the 
absorption spectra of BphP1 induced by the light illumination inside the spectrophotometer 
were negligible.
The photoswitching of BphP1 in Figure 2a was performed by using 780/25 nm and 630/25 
nm LEDs, which were mounted orthogonal to the optical beam path of the 
spectrophotometer to avoid detection interference. BphP1 was photoswitched directly in the 
100 µL quartz microcuvette of the spectrophotometer, while its absorbance at 780 nm was 
measured.
Mammalian cell culture
U87 cells were grown in DMEM medium supplemented with 10% FBS, penicillin-
streptomycin mixture, 2 mM glutamine (all from Life Technologies-Invitrogen) at 37°C in 
5% CO2 air atmosphere. U87 stable preclonal mixture was obtained by transfecting cells 
with pBphP1- IRES2-EGFP plasmid. Plasmid transfection was performed using an 
Effectene reagent (Qiagen). Cells were further selected with 700 µg/ml of G418 antibiotic 
for two weeks and enriched using a FACSAria sorter (BD Biosciences) equipped with a 488 
nm laser and a 530/30 nm emission filter. For further culturing of U87 cells stably 
expressing BphP1, the medium was additionally supplemented with 500 µg/ml of G418 
(Corning). To implant xenograph tumors into the animal (brain, kidney or liver), about 106 
U87 cells, either stably expressing BphP1 or un-modified, in 0.2 mL PBS were injected into 
mice with the guidance of a commercial ultrasound system (Vevo LAZR, Visualsonics). For 
photoacoustic microscopy with sub-diffraction resolution, U87 cells were plated into a 35 
mm glass-bottom petri dish (P35GCOL-0-14-C, MatTek).
Expression level of EGFP during prolonged culturing of BphP1-expressing U87 preclonal 
cell mixture was measured using a LSRII flow cytometer (BD Biosciences) equipped with a 
488 nm laser and a 530/40 nm emission filter. For cell viability assay, wild-type U87 cells 
and BphP1-expressing U87 cells were stained with annexin V conjugated with 
allophycocyanin dye according to manufacturer’s protocol (BD Biosciences). Cells were 
analyzed using the LSRII flow cytometer equipped with a 640 nm laser and 660/20 nm 
emission filter. The cell viability was estimated by the percentage of annexin V negative 
cells. Typically, the cell samples were triplicated, and at least 104 cells were analyzed per 
sample.
Animal preparation
Adult, two- to three-month-old nude mice (Hsd:Athymic Nude-FoxlNU, Harlan Co.; body 
weight: ~20−30 g; female) were used for all in vivo experiments. All experimental 
procedures were carried out in conformity with laboratory animal protocols approved by the 
Animal Studies Committee at the Washington University in St. Louis. Throughout the 
experiment, the mouse was maintained under anesthesia with 1.5% vaporized isoflurane. 
The mouse was taped to a lab-made motorized animal holder, which held the animal upright 
during imaging. The top of the holder was a small aluminum tube affixed to the animal’s 
nose and mouth, and the bottom was an aluminum cylinder attached to a permanent magnet. 
The magnet securely held the animal holder to the scanning stage for elevational scanning. 
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The animal’s fore and hind legs were taped to the top and bottom parts of the holder, 
respectively. The two parts were connected by four lengths of high-strength fishing line 
(0.13 mm diameter braided line). The combination of the magnet and a counterweight put 
the thin lines in tension to minimize holder movement caused by animal respiratory 
motion23. The animal’s trunk was immersed in water, and its body temperature was 
maintained at 37 °C by circulating the water through a heating bath outside the tank.
Hematoxylin and eosin (H&E) histology and fluorescence imaging
The tumor-bearing kidney and liver were harvested and fixed in 4% paraformaldehyde for 
24 h. Coronal sections (5 µm thick) were cut with paraffin embedding. Standard H&E 
staining was performed on the sections, which were examined using bright-field microscopy 
(NanoZoomer, Hamamatsu) with a 20× objective (NA = 0.67).
The harvested tissue and the BphP1-expressing U87 cells were also imaged by wide-field 
fluorescence microscopy (Fluoview 1000, Olympus), using the co-expressed EGFP protein 
(excitation wavelength: 488 nm; emission filter wavelength: 510 nm). A 4× objective (NA = 
0.10) was used to image the harvested tissue, and a 20× objective (NA = 0.70) was used to 
image the cells.
Whole-body photoacoustic computed tomography of reversibly switchable phytochrome 
BphP1 (RS-PACT)
The whole-body photoacoustic computed tomography system has been upgraded from our 
previous work23 (Fig. 1b). In order to image BphP1 and other control proteins, we have 
combined a Ti:Sapphire laser (LS-2137/LT-2211A, LOTIS) and a lab-made optical 
parametric oscillator (OPO) laser, each pumped by an Nd:YAG laser with a 10 Hz pulse 
repetition rate. The 780 nm light from the Ti:Sapphire laser is used for both whole-body PA 
imaging and switching off BphP1 at the same time, while the 630 nm light from the OPO 
laser is used for switching on the protein. The flashlamps of the two pump lasers are 
synchronized, and the two lasers are individually triggered by an FPGA-based controller 
(sbRIO9323, National Instruments). The two laser beams are combined by a dichroic mirror, 
and their incident fluences (in mJ/cm2) are measured by an optical power meter. The laser 
beam is first homogenized by an optical diffuser (EDC-5, RPC Photonics), and then passed 
through a conical lens (cone angle 130 °, Delmar Photonics) to form a ring-shaped light 
pattern. The light is then passed through an optical condenser to form a ring-shape light 
band around the animal’s trunk. The light incident area is aligned slightly above the acoustic 
focal plane to ensure sufficient light diffusion. The thickness of the light band is ~5 mm, and 
its diameter is similar to the cross-sectional diameter (~2−3 cm) of a mouse. The maximum 
light fluence on the skin of the animal is ~8 mJ/cm2, which is well below the American 
National Standards Institute (ANSI) safety limit.
The photoacoustic signals are detected by a full-ring ultrasonic transducer array (Imasonic) 
with a 5 cm diameter, 5 MHz central frequency, more than 80% one-way bandwidth, and 
512 elements. Each element (10 mm height, 0.3 mm pitch, and 0.1 mm inter-element space) 
is cylindrically focused to produce an axial focal distance of 19.8 mm (acoustic numerical 
aperture: 0.25). The combined foci of all 512 elements form an approximately uniform 
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imaging region with a 20 mm diameter and 1 mm thickness. Within this region, the radial 
resolution is 100 µm, and the tangential resolution is 100–250 µm, where the tangential 
direction is perpendicular to the radial direction. The tangential resolution depends on the 
radial distance from the center and degrades slowly with the radial distance. The data 
acquisition system has 64 channels with 8-fold multiplexing. The cross-sectional imaging 
speed is 1.6 s per frame. For image reconstruction, the raw data from each element is first 
Wiener deconvolved to account for the ultrasonic transducer’s impulse response and then 
reconstructed within each imaging plane, based on the universal back-projection 
algorithm37. To mitigate the artifacts induced by acoustic heterogeneities in the animal body, 
such as air cavities in gastrointestinal tract and backbone, the half-time image reconstruction 
algorithm is applied in combination with the universal back-projection reconstruction38.
Sub-diffraction photoacoustic microscopy of reversibly switchable phytochrome BphP1 
(RS-PAM)
As shown in Fig. 5a, a pulsed Nd:YLF laser (INNOSLAB, 523 nm, Edgewave) pumps a dye 
laser (CBR-D, Sirah) to provide 780 nm light for PA imaging and switching off BphP1. A 
CW 630 nm laser diode (Information Unlimited Inc.) switches on the protein. The light 
beams are combined by a dichroic mirror, reshaped by an iris (ID25SS, Thorlabs) and 
attenuated by a neutral density filter (NDC-50C-2M, Thorlabs). The attenuated beam is then 
split into two sub-beams (top and bottom) by a 50/50 beam splitter (BSW04, Thorlabs). The 
top beam is focused by a condenser lens (LA1131, Thorlabs) before passing through a 50 
µm pinhole (P50C, Thorlabs) for further spatial filtering. The filtered beam is then focused 
by an optical objective (AC127-050-A, Thorlabs. NA: 0.1 in air) into the object from the top. 
A beam combiner composed of a thin layer of silicone oil sandwiched by a right-angle prism 
(NT32-545, Edmund Optics) and a rhomboid prism (NT49-419, Edmund Optics) provides 
acoustic-optical coaxial alignment. The resultant photoacoustic waves are detected by an 
ultrasonic transducer (V214-BB-RM, Olympus-NDT) with a central frequency of 50 MHz. 
An acoustic lens with a 0.5 NA is ground into the bottom of the rhomboid prism to provide 
an acoustic focal diameter of 30 µm. An optical correction lens is attached to the top of the 
beam combiner to correct aberration. The acoustic lens is submerged in a water-tank for 
ultrasound coupling. The bottom beam duplicates the same path as the top beam, except that 
it is directly focused into the object from the bottom without going through the beam 
combiner and water-tank. The bottom objective has a 1.4 NA with oil immersion 
(MPLAPON100XO, Olympus). By carefully adjusting the positions of the two objectives, 
we achieve a confocal configuration of the two optical foci and the acoustic focus. 
Volumetric imaging is acquired by two-dimensional raster scanning of the object. A 
photodiode is added to monitor the fluctuations of the laser pulse energy.
The mechanism of the lateral resolution enhancement of RS-PAM is illustrated in Fig. 5b. 
The mathematical details are elaborated in Supplementary Notes 1–3. The effective lateral 
point spread function (PSF) of the system is ,where b is the power dependence 
of the switching-off rate on the excitation intensity (b=1 for Bphp1), m is the order of 
polynomial fitting of the signal decay (m=3 in this study), λ0 is the excitation wavelength, 
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and NA is the numerical aperture of the objective29. The lateral resolution of RS-PAM is 
finer than that of conventional PAM by a factor of .
In addition to the sub-diffraction lateral resolution, the nonlinear nature of the RS-PAM 
signal enables optical sectioning in the axial direction, which is of particular interest for 
large (or planar) targets. Compared with the in-focus molecules, the out-of-focus molecules 
are less affected during the switching-off process. Therefore, high-order coefficients 
extracted from the polynomial fitting of the signal decay contain mainly in-focus 
contributions, and thus RS-PAM achieves optical sectioning. Like the lateral resolution 
enhancement, the optical-sectioning strength of RS-PAM is determined by the power 
dependence of the switching-off rate on the excitation intensity. For point targets, RS-PAM 
can achieve an axial resolution of 30. For large targets, RS-PAM can 
achieve an axial resolution of .
Reproducibility
The experiments were not randomized. The investigators were not blinded to allocation 
during experiments and outcome assessment. No sample-size estimation was performed to 
ensure adequate power to detect a prespecified effect size.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Optical and photoacoustic characterization of the non-fluorescent bacterial phytochrome 
BphP1. (a) Molar extinction spectra of oxy-hemoglobin (HbO2), deoxy-hemoglobin (HbR), 
Pfr (ON) and Pr (OFF) state BphP1. (b) Schematic of the whole-body photoacoustic 
computed tomography (PACT) system with a ring-shaped illumination pattern. The 
Ti:Sapphire laser at 780 nm is used for PA imaging and switching off BphP1. The optical 
parametric oscillator (OPO) laser at 630 nm is used for switching on BphP1. (c) PA signal 
amplitudes of 30 µM purified ON state rsTagRFP, iRFP720, and ON state BphP1 in clear 
media, acquired at 567 nm, 715 nm and 780 nm. HbO2 concentration was 2.3 mM for the 
measurement at 715 nm and 780 nm, and was diluted to 23 µM for the measurement at 567 
nm. All the PA signal amplitudes were normalized by that of HbO2 acquired at 780 nm. 
Error bars, s.d. (d) PA images of transparent plastic tubes filled with proteins in clear media 
(left column) and with addition of 10 mm thick scattering media (right column). (e) PA 
signal of purified proteins acquired with increasing imaging depth up to 10 mm in scattering 
media. (f) Noise-equivalent detectable concentrations of purified proteins at different depths, 
acquired at their respective absorbing wavelengths. Error bars, s.d.
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Fig. 2. 
Optical and photoacoustic (PA) characterization of reversible photoswitching of BphP1. (a) 
Absorbance of BphP1 at 780 nm, switched off with 780 nm light illumination and then 
switched on with 630 nm light illumination. The photoswitching period was 180 seconds for 
both wavelengths, with an absorbance-rise half-time of 16 seconds and an absorbance-fall 
half-time of 8 seconds. (b) Switching on rate of BphP1 with 630 nm light illumination at 
different power levels. (c) Time sequences of the photoswitching cycle of BphP1. The 780 
nm light is used for PA imaging and switching off the protein, and. The PA signals are 
acquired only with the 780 nm illumination. (d) Switching ratio of purified proteins at 
different imaging depths in scattering media (1% intralipid and 10% gelatin in distilled 
water; reduced scattering coefficient of ~10 cm−1). We define switching ratio as the ratio 
between the PA signal amplitudes acquired in the ON and OFF states of the proteins. Error 
bars, s.d. (e) Differential PA images of the purified proteins at 10 mm depth, acquired at 
their respective wavelengths. HbO2 was imaged with each protein to provide a reference. (f) 
Comparison of the contrast to noise ratio quantified from the ON state images and the 
differential images. Error bars, s.d.
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Fig. 3. 
Deep PACT of genetically encoded reversibly switchable BphP1 in vivo. (a) PA contrast to 
noise ratio (CNR) of BphP1-expressing U87 cells embedded at 10 mm depth versus 
increasing cell counts, quantified from ON state and differential PA images shown in 
Supplementary Fig. 4b. Error bars, s.d. (b) In vivo whole-body PACT images of the kidney 
region of a nude mouse, acquired one week after injection of ~106 BphP1-expressing U87 
cells into the left kidney. The ON and OFF state PA images clearly show the major blood-
enriched internal organs, including the left kidney (LK), right kidney (RK), spinal cord (SC), 
renal vein (RV), bladder (BL), and spleen (SP). The differential image clearly reveals the 
tumor in the left kidney. (c) An overlay of the U87 tumor (shown in color) in the left kidney 
and the blood-dominated OFF state image (shown in gray). (d) Normalized signal profiles of 
the ON state, OFF state, and differential images along the white dashed line in (b). (e) A 
representative H&E histological image of the harvested left kidney, showing the tumor 
region. (f) Deep PACT of a mouse brain U87 tumor expressing BphP1. The tumor (shown in 
color) was ~3 mm beneath the scalp surface. A global threshold was applied to all the 
differential images with a threshold level at three times the noise level.
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Fig. 4. 
Longitudinal PACT monitoring of cancer metastasis in a mouse liver (n = 6). (a) Whole-
body PACT images of the liver region of a representative nude mouse acquired repeatedly 
for 30 days after the injection of BphP1-expressing U87 cells into the right liver lobe (n = 6). 
Differential signals (shown in color) are overlaid on top of the structural signals from the 
blood (shown in gray). The white arrows in the Day 21 and Day 30 images indicate 
secondary tumors due to metastasis. A global threshold was applied to all the differential 
images with a threshold level at three times the noise level. All the images were first 
thresholded and then normalized across the measurements. (b) Increase in areas of the 
primary and secondary tumors. Error bars: standard errors of the results from 6 animals. (c) 
Representative H&E histological images of the mouse liver lobes with the primary tumor 
(PT, top panel) and secondary tumors (ST, bottom panel).
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Fig. 5. 
Sub-diffraction photoacoustic microscopy of reversibly switchable BphP1 (RS-PAM). (a) 
Schematic of the double-illumination photoacoustic microscopy system. BS, beam splitter; 
DM, dichroic mirror; L1–2, laser beam 1 and 2; M, mirror; OL, optical lens; SOL, silicone 
oil layer; WT, water tank. Top objective NA: 0.1; Bottom objective NA: 1.4 with oil 
immersion. (b) Principle of RS-PAM with sub-diffraction resolutions. Within the diffraction-
limited excitation volume, some ON state BphP1 molecules (red dots) are switched to the 
OFF state, where the switching-off rate is proportional to the local excitation intensity. By 
fitting the nonlinear signal decay dynamics, RS-PAM improves the spatial resolution in all 
dimensions. (c) Conventional PAM and RS-PAM images of BphP1-expressing bacteria 
densely fixed on a cover glass, showing the superior lateral resolution of RS-PAM. (d) 
Close-up images of the dashed box regions in (c). (e) Normalized signal profiles across the 
two bacteria along the dashed lines in (d). (f) Depth-encoded RS-PAM image of a multiple 
layer of BphP1-expressing U87 cells fixed on a cover glass. The relative depths of the cells 
are color encoded from blue (superficial) to red (deep). (g) x–z cross-sectional images of 
two stacked U87 cells, acquired with conventional PAM and RS-PAM, showing the 
substantially finer axial resolution of RS-PAM.
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